SNPs in cytochromes P450 catalyzing cholesterol degradation in brain are associated with Parkinson’s disease DOI Creative Commons
Polina Petkova‐Kirova,

Anastasia Kolchina,

Stephan Baas

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: Sept. 30, 2024

Besides being an essential structural component of plasma membranes and the precursor many functional compounds signaling molecules, cholesterol was also proposed to play a role in etiology and/or manifestation Parkinson’s disease (PD). However, so far systematic investigations on its metabolites present brain for PD are missing. Here, we investigate first time association with SNPs genes four cytochromes P450 (P450), CYP46A1, CYP39A1, CYP27A1 CYP7B1, which critical degradation brain. Analyzing 1,349 individuals from PPMI data base, found 24 these genes, significantly over- or under-represented patients suffering idiopathic (IPD). Studying each 362 IPD individually, that most (45%) showed only one associated SNP while 31% displayed two 18% three SNPs. The occurrence some is same order magnitude as GBA (beta-glucocerebrosidase) thus might reflect genetic predisposition PD. As all were located introns 3′ untranslated regions, evaluated prospective regulatory impact surrounding genomic regions by using transcriptome epigenome Foundational Data Initiative Parkinson Disease (FOUNDIN-PD). FOUNDIN-PD provides gene expression, open chromatin DNA methylation cohort 89 induced pluripotent stem cell (iPSC) lines differentiated dopaminergic (DA) neurons derived people study. Indeed, SNPs, CYP7B1 (rs118111353) other (rs74446825), localized within region neurons. Interestingly, iPSC rs118111353 reference allele. P450, expressed neurons, discuss further studies connect expression levels. Finally, potential possibilities personalized therapeutic treatment investigated discussed.

Language: Английский

BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy DOI Creative Commons

Naif H. Ali,

Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

et al.

Journal of Cellular and Molecular Medicine, Journal Year: 2024, Volume and Issue: 28(10)

Published: May 1, 2024

Parkinson's disease (PD) is a neurodegenerative disorder of the brain and manifested by motor non-motor symptoms because degenerative changes in dopaminergic neurons substantia nigra. PD neuropathology associated with mitochondrial dysfunction, oxidative damage apoptosis. Thus, modulation apoptosis growth factors could be novel boulevard management PD. Brain-derived neurotrophic factor (BDNF) its receptor tropomyosin kinase type B (TrkB) are chiefly involved neuropathology. BDNF promotes survival nigra enhances functional activity striatal neurons. Deficiency TrkB triggers degeneration accumulation α-Syn As well, BDNF/TrkB signalling reduced early phase Targeting specific activators may attenuate this review aimed to discuss potential role against In conclusion, decreased linked severity long-term complications. Activation

Language: Английский

Citations

19

Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle DOI
Hayder M. Al‐kuraishy, Majid S. Jabir,

Ali K. Albuhadily

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 95, P. 102233 - 102233

Published: Feb. 14, 2024

Language: Английский

Citations

18

New insight on the possible role of statins in Vascular Parkinsonism: A need for presumptive therapy DOI
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 95, P. 102209 - 102209

Published: Jan. 28, 2024

Language: Английский

Citations

17

The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation DOI Open Access

Haydar M. Al‐kuraishy,

Majid S. Jabir,

Ali K. Albuhadily

et al.

Ageing Research Reviews, Journal Year: 2023, Volume and Issue: 91, P. 102084 - 102084

Published: Oct. 5, 2023

Language: Английский

Citations

35

Autophagy and autophagy signaling in Epilepsy: possible role of autophagy activator DOI Creative Commons

Naif H. Ali,

Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

et al.

Molecular Medicine, Journal Year: 2023, Volume and Issue: 29(1)

Published: Oct. 25, 2023

Abstract Autophagy is an explicit cellular process to deliver dissimilar cytoplasmic misfolded proteins, lipids and damaged organelles the lysosomes for degradation elimination. The mechanistic target of rapamycin (mTOR) main negative regulator autophagy. mTOR pathway involved in regulating neurogenesis, synaptic plasticity, neuronal development excitability. Exaggerated activity associated with temporal lobe epilepsy, genetic acquired experimental epilepsy. In particular, complex 1 (mTORC1) mainly epileptogenesis. investigation autophagy’s involvement epilepsy has recently been conducted, focusing on critical role rapamycin, autophagy inducer, reducing severity induced seizures animal model studies. induction could be innovative therapeutic strategy managing Despite protective against epileptogenesis its status epilepticus (SE) perplexing might beneficial or detrimental. Therefore, present review aims revise possible

Language: Английский

Citations

31

The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon DOI
Hayder M. Al‐kuraishy,

Sadiq M. Al‐Hamash,

Majid S. Jabir

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 94, P. 102200 - 102200

Published: Jan. 17, 2024

Language: Английский

Citations

10

Liver X Receptors (LXRs) in cancer-an Eagle’s view on molecular insights and therapeutic opportunities DOI Creative Commons
Prasanna Srinivasan Ramalingam, Sujatha Elangovan, M. Janaki Ramaiah

et al.

Frontiers in Cell and Developmental Biology, Journal Year: 2024, Volume and Issue: 12

Published: March 14, 2024

Cancer has become a serious health burden that results in high incidence and mortality rates every year, mainly due to various molecular alterations inside the cell. Liver X receptors (LXRs) dysregulation is one among them plays vital role cholesterol metabolism, lipid metabolism inflammation also crucial diseases such as obesity, metabolic dysfunction-associated fatty liver disease (MAFLD), cardiovascular diseases, Type 2 diabetes, osteoporosis, cancer. Studies report activation of LXRs inhibits cancer growth by inhibiting cellular proliferation, inducing apoptosis autophagy, regulating signalling pathways Wnt, PI3K/AKT, modulating expression levels cell-cycle regulators, promoting antitumor immunity tumor microenvironment. In this review, we have discussed role, structure, functions summarized their ligands along with mechanism action. addition, cancers, microenvironment (TME) importance precision medicine LXR-targeted therapies been emphasize potent targets for development novel therapeutics.

Language: Английский

Citations

9

The conceivable role of prolactin hormone in Parkinson disease: The same goal but with different ways DOI

Haydar M. Al‐kuraishy,

Majid S. Jabir, Ali I. Al‐Gareeb

et al.

Ageing Research Reviews, Journal Year: 2023, Volume and Issue: 91, P. 102075 - 102075

Published: Sept. 14, 2023

Language: Английский

Citations

23

Endoplasmic Reticulum Stress and Its Impact on Adipogenesis: Molecular Mechanisms Implicated DOI Open Access

G.D. Kim,

Jiyoon Lee, Joohun Ha

et al.

Nutrients, Journal Year: 2023, Volume and Issue: 15(24), P. 5082 - 5082

Published: Dec. 12, 2023

Endoplasmic reticulum (ER) stress plays a pivotal role in adipogenesis, which encompasses the differentiation of adipocytes and lipid accumulation. Sustained ER has potential to disrupt signaling unfolded protein response (UPR), thereby influencing adipogenesis. This comprehensive review illuminates molecular mechanisms that underpin interplay between We delve into dysregulation UPR pathways, namely, IRE1-XBP1, PERK ATF6 relation adipocyte differentiation, metabolism, tissue inflammation. Moreover, we scrutinize how impacts key adipogenic transcription factors such as proliferator-activated receptor γ (PPARγ) CCAAT-enhancer-binding proteins (C/EBPs) along with their interaction other pathways. The cellular ramifications include alterations adipokines, aged adipose also discuss roles chaperones cyclophilin A B play By shedding light on intricate relationship this paves way for devising innovative therapeutic interventions.

Language: Английский

Citations

19

The potential role of brain renin‐angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat? DOI Creative Commons
Zainah Al‐Qahtani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

et al.

Journal of Cellular and Molecular Medicine, Journal Year: 2024, Volume and Issue: 28(12)

Published: June 1, 2024

Abstract Parkinson disease (PD) is one of the most common neurodegenerative diseases brain. Of note, brain renin‐angiotensin system (RAS) intricate in PD neuropathology through modulation oxidative stress, mitochondrial dysfunction and neuroinflammation. Therefore, RAS by angiotensin receptor blockers (ARBs) angiotensin‐converting enzyme inhibitors (ACEIs) may be effective reducing risk neuropathology. It has been shown that all components including peptides enzymes are present different areas. Brain plays a critical role regulation memory cognitive function, controlling central blood pressure. However, exaggerated implicated pathogenesis PD. Two well‐known pathways recognized including; classical pathway which mainly mediated AngII/AT1R detrimental effects. Conversely, non‐classical mostly ACE2/Ang1‐7/MASR AngII/AT2R beneficial effects against Exaggerated affects viability dopaminergic neurons. fundamental mechanism was not fully elucidated. Consequently, purpose this review to disclose mechanistic In addition, we try revise how ACEIs ARBs can developed for therapeutics

Language: Английский

Citations

7